TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

_NL. Accessed on August 5 th 2010.
4A.125 Groupement pour le Dépistage, l‘Etude et la Prévention des Infections Hospitalières (GDEPIH). Mesures
préventives de la transmission du Staphylococcus aureus résistant à la méthicilline (MRSA)
dans les maisons de repos et de soins. Available at: http://www. belgian infectioncontrolsociety.be/in
dex.php?page=mrsa&hl=fr_FR. Accessed on August 5 th 210.
4A.126 Wiese-Posselt M et al. Successful termination of a furunculosis outbreak due to lukS-lukF-positive
methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-
2005. Clin Infect Dis 2007;44:e88-95.
4A.127 van Rijen MM et al. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical
patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008;61:254-61.
4A.128 Coia JE et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus
(MRSA) in healthcare facilities. J Hosp Infect 2006;63(suppl. 1):S1-44.
4A.129 Loveday HP et al. A systematic review of the evidence for interventions for the prevention and control
of methicillin resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working party
(subgroup A). J Hosp Infect 2006;63(suppl. 1):S45-70.
4A.130 Simor AE et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin,
and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus
aureus colonization. Clin Infect Dis 2007;44:178-85.
4A.131 Hammerlaan AS et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic
review. Clin Infect Dis 2009;48:922-30.
4A.132 Coates T et al. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses
and future prospects. J Antimicrob Chemother 2009;64:9-15.
4A.133 Gould FK et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus
aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 2009;63:849-61.
4A.134 Calfee DP et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in
acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl. 1):S62-80.
4A.135 Wertheim HF et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in
non surgical patients. Ann Intern Med 2004;140:419-25.
4A.136 Ellis MW et al. Targeted intranasal mupirocin to prevent colonization and infection by community-acquired
methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled
trial. Antimicrob Agents Chemother 2007;51:3591-8.
4A.137 Bode LG et al. Preventing surgical site infections in nasal carriers of Staphylococcus aureus. N Engl
J Med 2010;362:9-17.
4A.138 van Rijen MM et al. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical
patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008;61:254-61.
4A.139 Belgian Health Council. Prevention of perinatal group B streptococcal infections. Available at:
http://www.health.belgium.be/internet2Prd/groups/public/@public/@shc/documents/ie2divers/444839
1.pdf. Accessed on August 5th 2010.
4A.140 Edwards MS. Issues of antimicrobial resistance in group B Streptococcus in the era of intrapartum
antibiotic prophylaxis. Semin Pediatr Infect Dis 2006;17:149-52.
4A.141 Baltimore RS. Consequences of prophylaxis for group B streptococcal infections of the neonate. Semin
Perinatol 2007;31:33-8.
4A.142 Apgar BS et al. Prevention of group B streptococcal disease in the newborn. Am Fam Physician
2005;71:903-10.
4A.143 Puopolo KM et al. Early onset group B streptococcal disease in the era of maternal screening. Pediatrics
2005;115:1240-6.
4A.144 American Academy of Pediatrics Committee on Infectious Diseases. Group B streptococcal infections.
Red Book 2009;28:628-34.
4A.145 American College of Obstetricians and Gynecologists. Premature rupture of membranes. Obstet Gynecol
2007;109:1007-19.
4A.146 Ledger WJ. Prophylactic antibiotics in obstetrics – gynecology: a current asset, a future liability? Expert
Rev Anti Infect Ther 2006;4:957-64.
4A.147 Moore MR et al. Effects of intrapartum antimicrobial prophylaxis for prevention of group B streptococcal
disease on the incidence and ecology of early onset neonatal sepsis. Lancet Infect Dis 2003;3:
201-13.
4A.148 Hooton TM et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in
adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America.
Clin Infect Dis 2010;50:625-63.
4A.149 Trautner BW. Management of catheter-associated urinary tract infection. Curr Opin Infect Dis 2010;
23:76-82.
4A.150 Lo E et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals.
Infect Control Hosp Epidemiol 2008;29(suppl. 1):S41-50.
4A.151 Jepson RG et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev
2008;1:CD001321.
4A.152 Guay DR. Cranberry and urinary tract infections. Drugs 2009;69:775-807.
4A.153 McMurdo ME et al. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections?
A randomized controlled trial in older women. J Antimicrob Chemother 2009;63:389-95.
4A.154 Cimolai N et al. The cranberry and the urinary tract. Eur J Clin Microbiol Infect Dis 2007;26:767-76.
4A.155 American Academy of Pediatrics Committee on Quality Improvement Subcommittee on Urinary Tract
Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection
in febrile infants and young children. Pediatrics 1999;103:843-52.
4A.156 National Institute for Health and Clinical Excellence. Urinary tract infection in children; diagnosis,
treatment and long-term management. Available at: http://www.nice.org.uk/nicemedia/pdf/CG54full
guideline.pdf. Accessed on August 5th 2010.
4A.157 Hodson EM et al. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev
2007; 3:CD001532.
4A.158 Conway PH et al. Recurrent urinary tract infections in children. Risk factors and association with prophylactic
antimicrobials. J Am Med Assoc 2007;298:179-186.
4A.159 Garin EH et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis